UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010150 |
|---|---|
| Receipt number | R000010559 |
| Scientific Title | Phase I Study of Intratumoral Administration of HF10, Oncolytic Herpes Simplex Virus Type 1, in Patients with Advanced Unresectable Pancreatic Cancer |
| Date of disclosure of the study information | 2013/03/04 |
| Last modified on | 2016/04/11 17:24:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/03/02 18:51:12 | ||
| 2 | Update | 2013/03/02 18:55:16 | Date of disclosure of the study information |
|
| 3 | Update | 2013/04/15 16:49:09 | Public title |
|
| 4 | Update | 2013/04/15 16:52:21 | Narrative objectives1 Narrative objectives1 Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 5 | Update | 2013/04/15 17:00:55 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
| 6 | Update | 2013/04/15 17:02:11 | Organization |
|
| 7 | Update | 2013/04/18 18:56:30 | Anticipated trial start date |
|
| 8 | Update | 2013/05/01 13:34:37 | Recruitment status |
|
| 9 | Update | 2016/04/11 17:24:15 | Recruitment status Last follow-up date |
